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Although pericardial lipomas are both rare and benign, rapid or excessive growth can induce potentially fatal conditions such as
pericarditis, arrhythmia, and cardiac tamponade. This case illustrates an example where a 65-year-old with atypical chest
tightness unveiled a 10 × 15 cm anterior pericardial mass with circumferential eﬀusion and progressive deterioration to cardiac
tamponade. Initial transthoracic echocardiogram imaging was technically diﬃcult in this patient due to habitus and body mass,
which failed to illustrate underlying eﬀusion. Recurrent bouts of refractory supraventricular tachycardia prompted further
investigation of this patient’s presentation with transesophageal echocardiogram, which showed evidence of an echogenic mass
with cardiac tamponade. An urgent pericardial window and pericardial lipectomy immediately relieved this hemodynamically
compromising condition. Subsequent atrial ﬂutter resulted with the removal of the anterior fat pad during surgery, complicating
recovery.

1. Introduction
Pericardial tumors are exceptionally rare, composing only
6.7-12.8% of all primary cardiac neoplasms [1, 2]. Cardiac
tumors can present asymptomatically with incidental
ﬁndings on imaging or arise with a myriad of symptoms
dependent on location, size, and subtype. Pericardial lipomas
are benign pericardial neoplasms with a predominance of
adipose cells which generally grow insidiously but can
expand to compress and irritate adjacent structures via mass
eﬀect [3]. Rarely, they can induce ﬂuid inﬁltration into the
pericardial sac due to inﬂammatory mechanisms, resulting
in pericarditis [4].

2. Case Presentation
A 65-year-old female presented to the emergency department with pleuritic chest pain, tachycardia, and eructation.
The chest pain was characterized as a “band-like” chest tightness that radiated to the left axilla accompanied with associ-

ated shortness of breath, racing heart, and belching. The
patient denied nausea, emesis, diaphoresis, and loss of
motor/sensory function. The past medical history was significant for type II diabetes, tobacco use, obesity, and hyperlipidemia. The patient’s body mass index (BMI) was calculated
to be 35.4 upon admission. Family history revealed heart disease in the mother and a noncontributory surgical history.
The patient was normotensive, afebrile, and tachycardic with
a pulse of 128 bpm and SpO2 of 94%. Physical exam initially
presented without pathologic ﬁndings.
In light of tachycardia, multiple risk factors, and pleuritic
chest pain, a pulmonary embolism workup ensued.
Electrocardiogram (EKG) showed sinus tachycardia of
139 bpm (Figure 1(a)), and chest X-ray indicated cardiomegaly (Figure 2(a)). Subsequent blood work demonstrated a
negative D-dimer of 0.3 ug/mL with unremarkable thyroidstimulating hormone (TSH) and serial troponins. Additional
tests showed an elevated white blood cell (WBC) count of
23.8 K/uL and lactic acid of 2.3 mmol/L (Table 1). A computerized tomography scan for pulmonary embolism (CT/PE)
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Figure 1: EKG before (a) and after (b) pericardial lipoma resection. (a) Findings: supraventricular tachycardia (197 bpm) with low voltage
QRS. (b) Findings: normal sinus rhythm (91 bpm).

was then performed which displayed pericardial eﬀusion,
patchy bilateral pulmonary inﬁltrate, and pleural eﬀusions
(Figure 3). The setting of tachycardia, leukocytosis, and
pulmonary inﬁltrate initiated sepsis protocol. Based on
abnormal EKG ﬁndings and clinical presentation, the patient
was given ketorolac with colchicine for concern of potential
pericarditis, as well as azithromycin and ceftriaxone for
concern of potential bilateral atypical pneumonia. The
patient was then transferred to the intensive care unit
(ICU), cardiology was consulted, and a STAT transthoracic
echocardiogram (TTE) was ordered.
Transthoracic echocardiogram ﬁndings were limited and
failed to show cardiac tamponade or visualization of the
pulmonic valve (Figure 2(c)). Given the patient habitus and
unknown underlying tumor, the TTE was suboptimal. Later
that night, the patient’s tachycardia increased to over
200 bpm, prompting cardioversion. An initial dose of 10 mg
intravenous (IV) diltiazem returned the patient to sinus
tachycardia temporarily but rebounded to supraventricular
tachycardia (SVT). A dose of metoprolol 5 mg IV successfully

cardioverted her to sinus tachycardia. The patient was then
further stabilized with oxygen and pantoprazole. Given the
inconclusive TTE, the patient proceeded to transesophageal
echocardiogram (TEE) after stabilization to reevaluate a
potential mass and evidence of tamponade. The TEE
displayed right ventricular collapse, right atrial collapse, large
pericardial eﬀusion, evidence of tamponade, and an
echogenic mass in the pericardial eﬀusion (Figure 4). Cardiothoracic surgery deemed the patient a candidate for a pericardial window procedure to treat the eﬀusion and tamponade.
While a cardiac MRI was brieﬂy considered, the evidence of
tamponade and recurrent SVT prompted immediate surgical
intervention rather than additional imaging studies.
The surgical procedure unsheathed a large 10 × 15 cm
lipoma in the retrosternal space. This mass was excised and
sent to pathology for analysis. Underneath the prepericardial
pad, a bulging pericardium was exposed. A small incision in
the pericardium expressed 400 mL of dark serosanguinous
ﬂuid from around the heart which was sent for cytology,
culture, and cell count (Table 2). During surgery, the
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Figure 2: CXR/TTE before (left) and after (right) pericardial lipoma resection. (a) Findings: enlarged cardiac silhouette with epicardial fat pad
sign. Impression: cardiomegaly with mild left basilar atelectasis. (b) Findings: the cardiomediastinal silhouette appears WNL. No evidence of
pulmonary vascular congestion. Impression: no acute process. (c) Findings: moderately sized pericardial eﬀusion presents circumferentially
around the entire heart. (d) Findings: no evidence of cardiac tamponade and minimal remnant pericardial eﬀusion.
Table 1: Preliminary laboratory values.
CBC labs
WBC
RBC
Hg
Hct
Plt

Patient’s value

Reference range

Additional tests

Patient’s value

Reference range

23.8
4.93
14.2
37.2
390

3.8–10.6 K/uL
4.15–5.55 M/uL
12.0–15.0 g/dL
36–46%
150–450 K/uL

BUN
Cr
D-dimer
Lactic acid
Troponin

14
.77
.3
2.1
<40, <40

10–25 mg/dL
<1.03 mg/dL
0–0.50 ug/mL
0–2.1 mmol/L
0–50 ng/L

pericardium was noted to be thickened and inﬂamed; thus,
a 3 × 3 cm biopsy was sent for histologic analysis. The epicardium was also noted to have chronic and acute inﬂammatory changes. A chest tube was then inserted, and the
patient was taken to recovery after extubation.
Pericardial biopsy demonstrated ﬁbroadipose tissue consistent with an inﬂammatory pericarditis (Figure 5) and
benign adipocytes consistent with pericardial lipoma
(Figure 6). The pericardial ﬂuid cytology was negative for
malignancy and failed to culture acid-fast organisms. Fluid
amylase, glucose, protein, triglycerides, and cholesterol were
all within normal limits (Table 2). Eﬀusion lactate dehydro-

genase (LDH) was greatly elevated at 1,324 IU/L. Given the
lab values, etiology was deemed to be an inﬂammatory
pericarditis.
Postoperatively, the patient was initially unremarkable
and transferred to the surgical ICU. Later that night, the
patient developed new onset atrial ﬂutter status post pericardial window and was placed on diltiazem for rate control.
After insuﬃcient rate control, sotalol was added to the
treatment regimen along with apixaban for anticoagulation
due to the patient’s CHADSVASC score of 3. The patient
was stabilized in the ICU, and SVT was managed until
stabilization for 6 days. Colchicine and ibuprofen were
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Figure 3: CT pulmonary angiography. Findings: ∗ pericardial
eﬀusion: 15.4 mm (shown). †pericardial mass; ‡epicardial fat.
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Figure 4: Transesophageal echocardiogram. Findings:
ventricular diastolic collapse with †pericardial eﬀusion.

∗
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prescribed as initial treatment for the patient’s inﬂammatory
pericarditis. Repeat echocardiogram showed no evidence of
tamponade and minimal remnant pericardial eﬀusion
(Figure 2(d)). The patient’s chest tube was removed, and
she was discharged postoperatively on day 6 with apixaban
5 mg, colchicine 0.6 mg, diltiazem 30 mg, and sotalol 80 mg.
The patient was instructed to follow up with outpatient cardiology to monitor recovery and manage her new postoperative arrhythmia.

3. Discussion
Cardiac lipomas are typically asymptomatic, benign heart
tumors composed of mature adipocytes void of cellular atypia originating from the subendocardium [5]. However,
these lipomas can turn symptomatic in rare circumstances
when allowed to grow suﬃciently substantial in size. Large
cardiac lipomas can cause a wide spectrum of symptoms such
as chest pain, exertional dyspnea, arrhythmia, syncope, and
lower extremity edema depending on their size and location
[3]. Reports have also implicated these neoplasms as causes
of sudden death [6]. Pericardial lipomas are an especially rare
subset of cardiac lipomas and can present with unique complications due to their location.
Typically, pericardial lipomas are asymptomatic, with
incidental ﬁndings found on computerized tomography

(CT) or magnetic resonance imaging (MRI) [3]. It is in rare
circumstances that these lipomas present symptomatically
and even more unusual to be substantial enough to induce
cardiac tamponade. In this case, there were two leading theories regarding causalities of cardiac tamponade: cardiac
compression by pericardial lipoma leading to hemodynamic
compromise or inﬂammation resulting in ﬁbrosis and
pericardial ﬂuid accumulation due to extracellular matrix
destruction and increased vascular ﬁltration [7]. For this
patient, biopsies of the cardiac muscle and pericardium conﬁrmed that cardiac tamponade was induced by activation of
proinﬂammatory markers from the patient’s giant 10 × 15
cm anterior pericardial lipoma. Lymphocytic inﬁltration of
the cardiac muscle was negative for ﬁbrosis, suggesting acute
phase presentation of disease (Figure 7). Had intervention
been further delayed, myocarditis may have ensued.
In the instance of a suspected cardiac tumor, transthoracic echocardiogram is most commonly the initial method
of imaging investigation due to its ease of access and noninvasive application [8]. With 90% sensitivity and 95% speciﬁcity, echocardiography provides dynamic evaluation when
detecting cardiac tumors with capacity for physiologic characterization of consequences [9]. However, transesophageal
echocardiography may provide a better, unobstructed view
of the heart as it is not limited by an acoustic window and
is uninterrupted by the chest wall or lungs [10]. In nonemergent situations, enhanced evaluation and conﬁrmatory
testing for a suspected cardiac lipoma can be achieved with
cardiac computerized tomography (CCT) and cardiac
magnetic resonance (CMR) [10, 11]. A positron emission
tomography and computed tomography (PET-CT) scan
should also be obtained when attempting to accurately identify the presence or absence of metabolic activity within a suspected mass and reveal possible sites of lesion metastasis.
Ultimately, diagnosis of a nonspeciﬁc cardiac mass requires
specimen biopsy to understand its composition and origin.
Upon diagnosis of a pericardial lipoma, surgical excision
by median sternotomy is indicated as both the therapeutic
and diagnostic course of treatment [8]. With the incidence
of postoperative atrial ﬁbrillation after major thoracic surgery being not uncommon at >30% [12, 13], monitoring for
postoperative arrhythmias (usually atrial ﬁbrillation or ﬂutter) has become common practice for these procedures
[14]. However, this elevated awareness does not mean
arrhythmias are of little consequence, as resultant hemodynamic compromise and thromboembolism are serious contributors to morbidity and mortality in these patients [15].
Prophylactic drug therapy is currently the best method for
avoiding postoperative arrhythmic complications and should
be considered when managing a patient after the excision of a
pericardial lipoma [16]. Sotalol has demonstrated eﬃcacy as
a prophylactic agent for postoperative arrhythmias when
compared to placebo, with amiodarone being useful as an
additional agent in high-risk patients [17]. Alternatively,
recent evidence suggests that preservation of the anterior cardiac fat pad during lipoma resection may also reduce the risk
of postoperative arrhythmias [18]. While this modiﬁed technique does have the potential to reduce the incidence of postoperative arrhythmia, it is uncertain as to whether it would
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Table 2: Fluid analysis consistent with inﬂammatory pericarditis.

Test
Albumin
Amylase
Cholesterol
Glucose
LDH
Protein

Patient’s value

Reference range

Tests/culture

Patient’s value

Reference range

2.6
16
125
86
1,342
67

0–4.6 g/dL
0–100 IU/L
0–200 mg/dL
0–100 mg/dL
0–220 IU/L
<8.2 g/dL

TAG
RBC
WBC
Bacteria culture
Fungal culture
AFB culture

67
67,481
4,228
Negative
Negative
Negative

0–200 mg/dL
Cu/mm (N/A)
Cu/mm (N/A)
N/A
N/A
N/A

(a)

(b)

Figure 5: Pericardial biopsy on low power (a) and high power 40x (b). Findings: inﬂamed hemorrhagic pericardium with lymphocytic
involvement.

(a)

(b)

Figure 6: Pericardial lipoma biopsy on low power (a) and high power 40x (b). Findings: benign adipocytes consistent with lipoma. Negative
for malignancy.

(a)

(b)

Figure 7: Cardiac biopsy on low power (a) and high power 40x (b). Findings: Lymphocytic inﬁltration into cardiac muscle, suggestive of
myocarditis.

6
have signiﬁcantly decreased the likelihood of postoperative
arrhythmia and concomitant life-long medical therapy in
this case.

4. Summary
Chest pain, while a common presentation, can be benign or
potentially fatal. Casting a wide diﬀerential while working
up chest pain, rather than defaulting judgment to solely common presentations, can have a signiﬁcant impact on patient
care. While patients with benign pericardial tumors carry a
good prognosis, acute irritation can result in long-term complications and even fatality if not recognized and managed
correctly.
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